Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis

Ticker
ADVENZYMES.NSE

Price
271.95
Stock movement down
-0.65 (-0.24%)
Company name
Advanced Enzyme Technologies Limited
Exchange
(NSE
,
Currency
INR
)
Sector
Basic Materials >
Specialty Chemicals
Market cap
30.44B
Ent value
31.40B
Price/Sales
4.31
Price/Book
2.05
Div yield
-
Div growth
-
Growth years
-
FCF payout
0.10%
Trailing P/E
20.65
Forward P/E
16.79
PEG
-
EPS growth
0.24%
1 year return (CAGR)
-18.59%
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Last updated: 2026-01-22

DIVIDENDS

ADVENZYMES.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E20.65
Price to OCF14.69
Price to FCF19.63
Price to EBITDA15.98
EV to EBITDA16.49

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales4.31
Price to Book2.05
EV to Sales4.44

FINANCIALS

Per share

Loading...
Per share data
Current share count111.93M
EPS (TTM)13.17
FCF per share (TTM)13.86

Income statement

Loading...
Income statement data
Revenue (TTM)7.07B
Gross profit (TTM)4.80B
Operating income (TTM)1.79B
Net income (TTM)1.47B
EPS (TTM)13.17
EPS (1y forward)16.20

Margins

Loading...
Margins data
Gross margin (TTM)67.96%
Operating margin (TTM)25.27%
Profit margin (TTM)20.85%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash623.57M
Net receivables1.26B
Total current assets9.33B
Goodwill3.48B
Intangible assets504.34M
Property, plant and equipment3.15B
Total assets16.92B
Accounts payable293.01M
Short/Current long term debt346.54M
Total current liabilities1.07B
Total liabilities1.58B
Shareholder's equity14.85B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)2.07B
Capital expenditures (TTM)521.46M
Free cash flow (TTM)1.55B
Dividends paid (TTM)1.52M

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity9.93%
Return on Assets8.71%
Return on Invested Capital9.87%
Cash Return on Invested Capital10.38%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open275.00
Daily high278.35
Daily low269.45
Daily Volume81K
All-time high549.90
1y analyst estimate440.00
Beta0.35
EPS (TTM)13.17
Dividend per share0.00
Ex-div date23 Jul 2025
Next earnings date6 Feb 2026

Downside potential

Loading...
Downside potential data
ADVENZYMES.NSES&P500
Current price drop from All-time high-50.55%-0.89%
Highest price drop-52.75%-19.00%
Date of highest drop28 Feb 20258 Apr 2025
Avg drop from high-39.98%-2.49%
Avg time to new high-6 days
Max time to new high327 days89 days
COMPANY DETAILS
ADVENZYMES.NSE (Advanced Enzyme Technologies Limited) company logo
Marketcap
30.44B
Marketcap category
Large-cap
Description
Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and nutrition, animal nutrition, fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as for specialty applications, biofuels, and bio-catalysis. It also provides non-food processing enzymes for textile, leather, and pulp and paper processing, as well as detergents and cleaning aids. The company was formerly known as Advanced Biochemicals Limited and changed its name to Advanced Enzyme Technologies Limited in 2005. Advanced Enzyme Technologies Limited was founded in 1957 and is headquartered in Thane, India.
Employees
338
Investor relations
-
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found